XML 27 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Income Taxes
6 Months Ended
Jun. 30, 2022
Income Taxes [Abstract]  
Income Taxes 8.INCOME TAXES

Income tax expense or benefits are recorded relative to the jurisdictions that recognize book earnings. For the six months ended June 30, 2022, the Company recognized an income tax benefit of ($9.0) million on pre-tax earnings of $3.6 million, representing an effective income tax rate of (251.4%) compared to income tax expense of $1.2 million on pre-tax earnings of $5.6 million, representing an effective income tax rate of 21.8% for the same period in 2021. The comparison of pre-tax earnings of $3.6 million for the six months ended June 30, 2022 to the pre-tax earnings of $5.6 million for the six months ended June 30, 2021 should be considered when comparing effective tax rates for the respective periods.

For the six months ended June 30, 2022, the Company computed an annual effective tax rate using forecasted information. Based on current forecasts, the Company’s effective tax rate is expected to be highly sensitive to changes in earnings. The Company concluded that computing its effective tax rate using forecasted information would be appropriate in estimating tax expense for the six months ended June 30, 2022.

A number of items caused the effective income tax rate for the six months ended June 30, 2022 to differ from the US federal statutory income tax rate of 21%, including taxation of global intangible low-tax income (GILTI) in the United States, a 23% statutory tax rate in Canada, certain nondeductible business expenses in Poland, and various exchange rate benefits. Furthermore, management has determined that there is significant positive evidence to conclude that it is more likely than not that the deferred tax assets in the United States will be realized. As a result, the valuation allowance against these deferred tax assets has been released, resulting in a $10.2 million income tax benefit recognized during the second quarter of 2022. As of June 30, 2022, the Company continues to maintain a full valuation allowance on deferred tax assets for CMR and CRM.

Additionally, the Company has unrecognized tax benefits of $0.8 million, of which $0.7 million is due to the Company’s ability to utilize pre-acquisition net operating losses. Due to the lapse of statute of limitations related to the pre-acquisition net operating losses, the Company recognized a tax benefit of $0.2 million during the second quarter of 2022 and anticipates it will recognize a tax benefit of $0.5 million during 2023.